Arrhythmias & electrophysiology
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study
Study context
- Population
- Adults aged ≥18 years following ischemic strokeplanned
- Participants
- 1,000 adults
- Primary endpoint
- PPV of Huawei smart wearables for AF detection
- Follow-up
- 4 weeks postdischarge
Methodological detailsprotocol, multicentre, 4 participating hospitals, Recruitment opened May 30, 2022; open at 4 hospitals, first 106 participants recruited, Follow-up at 6 and 12 months; clinical outcomes recorded for prevalent and incident atrial fibrillation (AF) post-stroke
- Protocol
- Multicentre
- 4 participating hospitals
- Recruitment opened May 30, 2022; open at 4 hospitals, first 106 participants recruited
- Follow-up at 6 and 12 months; clinical outcomes recorded for prevalent and incident AF post-stroke
No results yet. This paper sets out the design of a trial; its results are to come.
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study. Am Heart J. Published 7 December 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →